Institute for Musculoskeletal Health, School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Sydney Local Health District, Sydney, NSW, Australia.
Int J Health Policy Manag. 2022 Aug 1;11(8):1595-1598. doi: 10.34172/ijhpm.2022.6833. Epub 2022 Feb 14.
Verkerk and colleagues explored the key drivers of low-value care from the perspective of 18 policy-makers and researchers who had led and evaluated at least one initiative to reduce low-value care or had been responsible for reducing low-value care in an organisation. They identified several drivers of low-value care presented in the 2017 Lancet Right Care Series (eg, fee for service payment systems, the pharmaceutical and medical device industry, fear of malpractice litigation, issues with research conduct and reporting, a culture of 'more is better' and 'new technology is better') but did not discuss some other important ones. In this commentary, we aim to extend the work of Verkerk and colleagues and provide some additional perspectives on the drivers of low-value care within the following categories: .
弗尔克和同事们从 18 位政策制定者和研究人员的角度探讨了低价值医疗的主要驱动因素,这些人员至少领导和评估过一项减少低价值医疗的举措,或曾负责在组织内减少低价值医疗。他们在 2017 年《柳叶刀 正确医疗系列》中确定了低价值医疗的几个驱动因素(例如,按服务收费支付系统、制药和医疗器械行业、对医疗事故诉讼的恐惧、研究开展和报告方面的问题、“越多越好”和“新技术更好”的文化),但没有讨论其他一些重要的驱动因素。在本评论中,我们旨在扩展弗尔克等人的工作,并在以下类别中就低价值医疗的驱动因素提供一些额外的观点:。